FDA VRBPAC Recommends JN.1 Boosters Despite Zero Prevalence
By Peter A. McCullough, MD, MPH The COVID-19 vaccine campaign stumbles into its fifth year with a decision on fall boosters for a JN.1 lineage that is now extinct. The FDA VRBPAC panel is betting that the now dominant LP.8.1 a JN.1 progenitor will still respond to the historically ineffective vaccines. Subscribe now Read more
Discuss on Nostr!
Nostr Note ID note13tyfpnad220fje8uxfzuaae6hz4ydr2lxa90drfc9r53ajq9xerqt9ee42 Open on Primal.net Open on Snort.social Open on Iris.to Open on Coracle.social
New to Nostr?
Create an account now & join the conversation!
Promote it on DissentWatch!
- To advertise this post for $0.02 per visit send bitcoins to the address below
- The post will be promoted daily via social media & our "Featured News" display in multiple places
- You can add more anytime
- Ranking order in the Featured News box is based on the balance remaining
Received: 0 mBTC (0.00 USD)
Spent: 0 mBTC (0.00 USD)
Balance: 0 mBTC (0.00 USD)
The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.